Impurity Profiling and Forced Degradation
Impurity profiling is the systematic process of detecting, quantifying, identifying, and characterising the impurities present within a drug substance or drug product, and constitutes a central pillar of pharmaceutical quality assurance because the safety of a medicinal product depends not only upon the efficacy of the active ingredient but equally upon the absence of impurities at concentrations capable of producing toxicity. This chapter examines the classification of pharmaceutical impurities, the regulatory thresholds governing their reporting, identification, and qualification, and the analytical strategies employed to characterise impurities of toxicological concern.
Chapter overview
The classification of pharmaceutical impurities, the regulatory thresholds governing their reporting and qualification, and the analytical strategies used to characterise them.
Impurity Profiling: Concept, Importance and Scope
Impurity profiling is the systematic process of detecting, identifying, quantifying, and characterizing impurities present in a pharmaceutical drug substance (API) or drug product. It is an essential part of pharmaceutical quality assurance because impurities can affect the safety, efficacy, and stability of medicines.
- Detect impurities present in a drug substance or drug product.
- Identify and characterize unknown impurities.
- Quantify impurities accurately.
- Ensure impurities remain within acceptable regulatory limits.
- Improve product quality and patient safety.
Impurity profiling is important because it:
- Ensures patient safety.
- Maintains batch-to-batch consistency.
- Supports regulatory approval.
- Helps in risk assessment and impurity control.
- Improves product quality and stability.
- Ensures compliance with ICH guidelines.
Pharmaceutical impurities can be classified in different ways.
A. Based on Origin
These impurities arise during manufacturing or storage.
- Process-related impurities – Formed during synthesis, manufacturing, or processing.
- Product-related impurities – Formed due to degradation during storage.
B. Based on Chemical Nature
Impurities may be classified as:
- Organic impurities
- Inorganic impurities
- Residual solvents
- Elemental impurities (metal impurities)
C. Based on Toxicological Concern
According to their safety risk, impurities include:
- Qualified impurities
- Unqualified impurities
- Genotoxic impurities
- Nitrosamine impurities
ICH guidelines define impurity limits based on the Maximum Daily Dose (MDD). There are three important thresholds:
1. Reporting Threshold
If an impurity exceeds this limit, it must be reported in analytical results.
2. Identification Threshold
If an impurity exceeds this limit, its chemical structure must be identified.
3. Qualification Threshold
If an impurity exceeds this limit, its biological safety must be demonstrated using toxicological data.
The process of impurity identification generally involves:
- Detection of impurity by HPLC or GC.
- Isolation of the impurity using preparative chromatography (if required).
- Structure determination using LC-MS, NMR, and FTIR.
- Toxicological evaluation to assess its safety.
- Documentation and regulatory reporting.
Different analytical techniques are used for impurity profiling.
Chromatographic Techniques
- HPLC
- UHPLC
- GC
- Capillary Electrophoresis (CE)
Used for separation and quantification of impurities.
Mass Spectrometry (MS)
- LC-MS
- GC-MS
- HRMS
Used to determine molecular weight and identify unknown impurities.
Spectroscopic Techniques
- UV-Visible Spectroscopy
- FTIR
- NMR
Used to determine the chemical structure and functional groups of impurities.
Elemental Impurity Analysis
- ICP-MS
- ICP-OES
Used to detect elemental impurities such as lead, arsenic, cadmium, and mercury.
Residual Solvent Analysis
- Headspace Gas Chromatography (HS-GC)
Used to detect and quantify residual organic solvents.
Some impurities require special attention because they may pose health risks.
1. Genotoxic Impurities
These impurities can damage DNA and may increase the risk of cancer.
2. Nitrosamine Impurities
Nitrosamines are potentially carcinogenic impurities that must be controlled at very low levels.
3. Elemental Impurities
Heavy metals such as:
- Lead (Pb)
- Arsenic (As)
- Cadmium (Cd)
- Mercury (Hg)
must be controlled according to ICH Q3D guidelines.
4. Residual Solvents
Organic solvents remaining after manufacturing should be controlled according to ICH Q3C guidelines.
A systematic impurity control strategy includes:
- Risk Assessment – Identify possible impurities and evaluate their risk.
- Control Strategy – Establish specifications and analytical methods.
- Routine Monitoring – Regularly monitor impurity levels during manufacturing and stability studies.
- Lifecycle Management – Continuously improve impurity control based on new data and regulatory updates.
Impurity profiling is a critical part of pharmaceutical quality assurance. It helps ensure that impurities are detected, identified, quantified, and controlled throughout drug development and manufacturing. Effective impurity profiling supports patient safety, regulatory compliance, product quality, and successful marketing approval by ensuring that impurities remain within acceptable limits specified by ICH guidelines.
- Impurity Profiling = Detection + Identification + Quantification + Characterization of impurities.
- Main Types of Impurities: Organic, Inorganic, Residual Solvents, and Elemental Impurities.
- Regulatory Thresholds: Reporting, Identification, and Qualification Thresholds.
- Common Analytical Techniques: HPLC, GC, LC-MS, HRMS, FTIR, NMR, ICP-MS, and HS-GC.
- Important ICH Guidelines: Q3A, Q3B, Q3C, Q3D, and M7.
- Goal: Ensure pharmaceutical products are safe, effective, and of high quality.
Key Takeaway
Impurity profiling is the systematic evaluation of impurities present in pharmaceutical products. It involves detecting, identifying, quantifying, and controlling impurities using advanced analytical techniques while complying with ICH regulatory guidelines. Proper impurity profiling ensures drug quality, patient safety, and regulatory approval, making it an essential component of pharmaceutical quality assurance.